Arginine facilitates inactivation of enveloped viruses

Journal of Pharmaceutical Sciences

Volumn 97, Issue 8, 2008, Pages 3067-3073

  Yamasaki, Hisashi ^a   Tsujimoto, Kazuko ^a   Koyama, Hajime ^a   Ejima, Daisuke ^b   Arakawa, Tsutomu ^c  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c ALLIANCE PROTEIN LABORATORIES   (United States)

Author keywords

Arginine; Butyroyl arginine; Low pH; Monoclonal antibodies; Viral safety; Virus inactivation

Indexed keywords

ARGININE; CITRATE SODIUM; MONOCLONAL ANTIBODY;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; INFLUENZA VIRUS; NONHUMAN; SENSITIVITY ANALYSIS; VIRUS ENVELOPE; VIRUS INACTIVATION; VIRUS SURVIVAL;

EID: 47949113253     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21224     Document Type: Article

References (31)

1. Zafir-Lavie I, Michaeli Y, Reiter Y. 2007. Novel antibodies as anticancer agents. Oncogene 26: 3714-3733.
2. Li Y, Zhu Z. 2007. Monoclonal antibody-based therapeutics for leukemia. Expert Opin Biol Ther 7:319-330.
3. Buchacher A, Iberer G. 2006. Purification of intravenous immunoglobulin G from human plasma-aspects of yield and virus safety. Biotechnol J 1:148-163.
4. Preuss T, Kamstrup S, Kyvsgaard NC, Nansen P, Miller A, Lei JC. 1997. Comparison of two different methods for inactivation of viruses in serum. Clin Diagn Lab Immunol 4:504-508.
5. Brorson K, Krejci S, Hamilton E, Stein K, Xu Y. 2003. Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. Biotechnol Bioeng 82:321-329.
6. Brorson K, Norling L, Hamilton E, Lute S, Lee K, Curtis S, Xu Y. 2004. Current and future approaches to ensure the viral safety of biopharmaceuticals. Dev Biol 118:17-29.
7. Farshid M, Taffs RE, Scott D, Asher DM, Brorson K. 2005. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals. Curr Opin Biotechnol 16:561-567.
8. Shi L, Chen Q, Norling LA, Lau AS, Xu Y. 2004. Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification. Biotechnol Bioeng 87:884-896.
9. Vermeer AWP, Norde W. 2000. The thermal stability of immunoglobulin: Unfolding and aggregation of a multi-domain protein. Biophys J 78:394-404.
10. 2 domain of rabbit IgG after acid treatment as evidenced by differential scanning calorimetry. Immunol Lett 43:149-152.
11. Martsef SP, Kravxhuk ZI, Vlasov AP, Lyakhnovich GV. 1995. Thermodynamic and functional characterization of a stable IgG conformer obtained by renaturation from a partially structured low pH-induced state. FEBS Lett 361:173-175.
12. Ejima D, Tsumoto K, Fukada H, Yumioka R, Nagase K, Arakawa T, Philo JS. 2007. Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies. Proteins 66:954-962.
13. Ejima D, Yumioka R, Tsumoto K, Arakawa T. 2005. Effective elution of antibodies by arginine and arginine derivatives in affinity column chromatography. Anal Biochem 345:250-257.
14. Arakawa T, Philo JS, Tsumoto K, Yumioka R, Ejima D. 2004. Elution of antibodies from a Protein-A column by aqueous arginine solutions. Protein Expr Purif 36:244-248.
15. Ishihara T, Kadoya T, Yoshida H, Tamada T, Yamamoto S. 2005. Rational methods for predicting human monoclonal antibodies retention in protein A affinity chromatography and cation exchange chromatography. Structure-based chromatography design for monoclonal antibodies. J Chromatogr A 1093:126-138.
16. Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. 2007. Downstream processing of monoclonal antibodies - Application of platform approaches. J Chromatogr B Analyt Technol Biomed Life Sci 848:28-39.
17. Koyama AH, Uchida T. 1989. The effect of ammonium chloride on the multiplication of herpes simplex virus type 1 in Vero cells. Virus Res 13:271-282.
18. Kurokawa M, Koyama AH, Yasuoka S, Adachi A. 1999. Influenza virus overcomes apoptosis by rapid multiplication. Int J Mol Med 3:527-530.
19. Koyama AH, Irie H, Ueno F, Ogawa M, Nomoto A, Adachi A. 2001. Suppression of apoptotic and necrotic cell death by poliovirus. J Gen Virol 8:2965-2972.
20. Lamb RA, Krug RM. 2001. Orthomyxoviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 4th edition. New York: Lippincott-Raven. pp 1487-1530.
21. Lakadamyali M, Rust MJ, Zhuang X. 2004. Endocytosis of influenza viruses. Microbes Infect 6:929-936.
22. Roberts P. 1996. Virus safety of plasma products. Rev Med Virol 6:25-38.
23. Roberts PL, Lloyd D. 2007. Virus inactivation by protein denaturants used in affinity chromatography. Biologicals 36:1-5.
24. Boot HJ, Kasteel DT, Buisman AM, Kimman TG. 2003. Excretion of wild-type and vaccine-derived poliovirus in the feces of poliovirus receptor-trans-genic mice. J Virol 77:6541-6545.
25. Gassilloud B, Gantzer C. 2005. Adhesion-aggregation and inactivation of poliovirus 1 in groundwater stored in a hydrophobic container. Appl Environ Microbiol 71:912-920.
26. Arakawa T, Ejima D, Tsumoto K, Obeyama N, Tanaka Y, Kita Y, Timasheff SN. 2007. Suppression of protein interactions by arginine: A proposed mechanism of the arginine effects. Biophys Chem 127:1-8.
27. Arakawa T, Kita Y, Ejima D, Tsumoto K, Fukada H. 2006. Aggregation suppression of protein by arginine. Protein Pet Lett 13:921-927.
28. Tsumoto K, Ejima D, Kita Y, Arakawa T. 2005. Review: Why is arginine effective in suppressing aggregation? Protein Pept Lett 12:613-619.
29. Ishibashi M, Tsumoto K, Tokunaga M, Ejima D, Kita Y, Arakawa T. 2005. Is arginine a protein-denaturant? Protein Expr Purif 42:1-6.
30. Kita Y, Arakawa T, Lin TY, Timasheff SN. 1994. Contribution of the surface free energy perturbation to protein-solvent interactions. Biochemistry 33:15178-15189.
31. Calnan BJ, Tidor B, Biancalana S, Hudson D, Frankel AD. 1991. Arginine-mediated RNA recognition: The arginine fork. Science 252:1167-1171.